Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-cash Items (2021 - 2025)

Organogenesis Holdings (ORGO) has 5 years of Non-cash Items data on record, last reported at $20.0 million in Q4 2025.

  • For Q4 2025, Non-cash Items rose 692.26% year-over-year to $20.0 million; the TTM value through Dec 2025 reached $20.0 million, up 692.26%, while the annual FY2025 figure was $20.0 million, 692.26% up from the prior year.
  • Non-cash Items reached $20.0 million in Q4 2025 per ORGO's latest filing, up from $10.8 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $38.5 million in Q4 2021 and bottomed at $1.5 million in Q1 2023.
  • Average Non-cash Items over 5 years is $7.8 million, with a median of $4.0 million recorded in 2023.
  • Peak YoY movement for Non-cash Items: tumbled 94.17% in 2022, then soared 692.26% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $38.5 million in 2021, then crashed by 94.17% to $2.2 million in 2022, then skyrocketed by 357.33% to $10.3 million in 2023, then tumbled by 75.45% to $2.5 million in 2024, then skyrocketed by 692.26% to $20.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $20.0 million in Q4 2025, $10.8 million in Q3 2025, and $6.4 million in Q2 2025.